Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia

被引:0
作者
Sobia Rana
Mustafa Munawar
Adeela Shahid
Meera Malik
Hafeez Ullah
Warda Fatima
Shahida Mohsin
Saqib Mahmood
机构
[1] University of Health Sciences,Department of Physiology & Cell Biology
[2] University of Health Sciences,Department of Allied Health Sciences
[3] University of Health Sciences,Department of Human Genetics & Molecular Biology
[4] University of the Punjab,Department of Microbiology & Molecular Genetics
[5] University of Health Sciences,Department of Hematology
来源
Molecular Biology Reports | 2014年 / 41卷
关键词
Circadian clock; Clock genes; Clock-controlled genes; Shift-work; Melatonin; Chronic lymphocytic leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
Circadian rhythms are endogenous and self-sustained oscillations of multiple biological processes with approximately 24-h rhythmicity. Circadian genes and their protein products constitute the molecular components of the circadian oscillator that form positive/negative feedback loops and generate circadian rhythms. The circadian regulation extends from core clock genes to various clock-controlled genes that include various cell cycle genes. Aberrant expression of circadian clock genes, therefore, may lead to genomic instability and accelerated cellular proliferation potentially promoting carcinogenesis. The current study encompasses the investigation of simultaneous expression of four circadian clock genes (Bmal1, Clock, Per1 and Per2) and three clock-controlled cell cycle genes (Myc, Cyclin D1 and Wee1) at mRNA level and determination of serum melatonin levels in peripheral blood samples of 37 CLL (chronic lymphocytic leukemia) patients and equal number of age- and sex-matched healthy controls in order to indicate association between deregulated circadian clock and manifestation of CLL. Results showed significantly down-regulated expression of Bmal1, Per1, Per2 and Wee1 and significantly up-regulated expression of Myc and Cyclin D1 (P < 0.0001) in CLL patients as compared to healthy controls. When expression of these genes was compared between shift-workers and non-shift-workers within the CLL group, the expression was found more aberrant in shift-workers as compared to non-shift-workers. However, this difference was found statistically significant for Myc and Cyclin D1 only (P < 0.05). Serum melatonin levels were found significantly low (P < 0.0001) in CLL subjects as compared to healthy controls whereas melatonin levels were found still lower in shift-workers as compared to non-shift-workers within CLL group (P < 0.01). Our results suggest that aberrant expression of circadian clock genes can lead to aberrant expression of their downstream targets that are involved in cell proliferation and apoptosis and hence may result in manifestation of CLL. Moreover, shift-work and low melatonin levels may also contribute in etiology of CLL by further perturbing of circadian clock.
引用
收藏
页码:95 / 103
页数:8
相关论文
共 259 条
[1]  
Reppert SM(2002)Coordination of circadian timing in mammals Nature 418 935-941
[2]  
Weaver DR(2003)A clockwork web: circadian timing in brain and periphery, in health and disease Nat Rev Neurosci 4 649-661
[3]  
Hastings MH(2009)How the skin can tell time J Invest Dermatol 129 1063-1066
[4]  
Reddy AB(2000)Interacting molecular loops in the mammalian circadian clock Science 288 1013-1019
[5]  
Maywood ES(2004)Finding new clock components: past and future J Biol Rhythms 19 339-347
[6]  
Geyfman M(2003)The circadian clock: pacemaker and tumor suppressor Nat Rev Cancer 3 350-361
[7]  
Andersen B(2003)DNA microarray analyses of circadian timing: the genomic basis of biological time J Neuroendocrinol 15 991-1002
[8]  
Shearman LP(2003)Control mechanism of the circadian clock for timing of cell division in vivo Science 302 255-259
[9]  
Sriram S(2002)The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo Cell 111 41-50
[10]  
Weaver DR(1999)Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis J Mol Med 77 266-281